Biomedical Engineering Reference
In-Depth Information
Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery
model.
Cardiovasc Intervent Radiol
2008;
31
(5): 971-980.
RAIZNER AE, OESTERLE SN, WAKSMAN R, SERRUYS PW, COLOMBO A, LIM YL, YEUNG AC, VAN
DER GIESSEN WJ, VANDERTIE L, CHIU JK, WHITE LR FI TZGERALD PJ, KALUZA GL and ALI
NM. Inhibition of restenosis with beta emitting radiotherapy: report on the Pro-
liferation Reduction with Vascular Energy Trial (PREVENT).
Circulation
2000;
102
: 951-958.
RAJTAR A, KALUZA GL, YANG Q, HAKIMI D, LIU D, TSUI M, LIEN M, SMITH D, CLUBB FJ JR
and TROCZYNSKI T. Hydroxyapatite-coated cardiovascular stents.
EuroInterven-
tions
2006;
2
: 113-115.
REIFART N, MORICE MC, SILBER S, BENIT E, HAUPTMANN KE, DESOUSA E, WEBB J, KAUL U,
CHAN C, THUESEN
et al.
The NUGGET study: NIR ultra gold-guilded equivalency
trial.
Catheter Cardiovasc Interv
2004;
62
: 18-25.
ROCHER P, EL MEDAWAR L, HORNEZ JC, TRAISNEL M, BREME J and HILDEBRAND HF. Bio-
corrosion and cytocompatibility assessment of NiTi shape memory alloys.
Scripta
Materialia
2004;
50
: 255-260.
ROUBIN GS, CANNON AD, AGRAWAL SK, MACANDER PJ, DEAN LS, BAXLEY WA and BRELAND
J. Intracoronary stenting for acute and threatened closure complicating percuta-
neous transluminal coronary angioplasty.
Circulation
1992;
85
: 916-927.
RUEF J, STÖRGER H, SCHWARZ F and HAASE J. Comparison of a polymer-free rapamycin-
eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS)
in real-world coronary artery lesions.
Catheter Cardiovasc Interv
2008;
71
(3):
333-339.
SALAHAS A, VRAHATIS A, KARABINOS I, ANTONELLIS I, IFANTIS G, GAVALIATSIS I,
ANTHOPOULOS P and TAVERNARAKIS A. Success, safety, and effi cacy of implantation
of diamond-like carbon coated stents.
Angiology
2007;
58
(2): 203-210.
SANTIN M, MIKHALOVSKA L, LLOYD AL, MIKHALOVSKY S, SIGFRID L, DENYER S, FI ELD SN
and TEER, D.
In vitro
host response assessment of biomaterials for cardiovascular
stent manufacture.
J Mater Sci: Mater Med
2004;
15
: 473-477.
SANTIN M, COLOMBO P and BRUSCHI G. Interfacial biology of in-stent restonosis.
Exp
Rev Med Dev
2005;
2
: 429-443.
SCHIELE TM, KROTZ F and KLAUSS V. Vascular restenosis - striving for therapy.
Expert
Opin Pharmacother
2004;
5
: 2221-2232.
SCHWARTZ RS. Polymers on stents: if you do not read history you are bound to repeat
it. Presented at Cardiovascular Radiation Therapy V and Restenosis Forum, 2001,
Feb 5-8, Washington, DC.
SCOTT NA, CANDAL FJ, ROBINSON KA and ADES EW. Seeding of intracoronary stents with
immortalized human microvascular endothelial cells.
Am Heart J
1995;
129
(5):
860-866.
SERRUYS PW and GERSHLICK AH (eds).
Handbook of Drug Eluting Stents
. London:
Tayor & Francis, 2005; 1-37.
SERRUYS PW, FOLEY DP, JACKSON G, BONNIER H, MACAYA C, VROLIX M, BRANZI A, SHER-
PHERD J, SURYPRANTHA H, FEYTER PJ DE, MELKERT R, ES GA, VAN and PFI STER PJ. A
randomized placebo-controlled trial of fl uvastatin for prevention of restenosis
after successful coronary balloon angioplasty: fi nal results of the fl uvastatin angi-
ograpgic restenosis (FLARE) trial.
Eur Heart J
1999;
20
: 58-69.
SERRUYS PW, RUYGROK P, NEUZNER J, PIEK JJ, SETH A, SCHOFER JJ
et al.
A randomized
comparison of an everolimus-eluting coronary stent with a Paclitaxel-eluting
coronary stent: the SPIRITII trial.
EuroIntervention
2006a;
2
: 286-294.
Search WWH ::
Custom Search